News
Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.
Telehealth company Hims & Hers reported first-quarter results late Monday that beat Wall Street estimates. But the company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback